Modulation of antibody-mediated glomerular injury in vivo by interleukin-6.

[1]  E. Kawashima,et al.  Recombinant human IL-6 expressed inE. coli undergoes selective N-terminal degradation: Evidence that the protein consists of a stable core and a nonessential flexible N-terminal , 1993, Journal of protein chemistry.

[2]  S. J. Cashman,et al.  Passive immunization against tumour necrosis factor‐alpha (TNF‐α) and IL‐lβ protects from LPS enhancing glomerular injury in nephrotoxic nephritis in rats , 1992 .

[3]  A. Rifai,et al.  Extrarenal cytokines modulate the glomerular response to IgA immune complexes. , 1992, Kidney international.

[4]  M. Denis.  Interleukin‐6 in mouse hypersensitivity pneumonitis: changes in lung free cells following depletion of endogenous IL‐6 or direct administration of IL‐6 , 1992, Journal of leukocyte biology.

[5]  C. Stewart,et al.  Inhibitory role of interleukin‐6 in macrophage proliferation , 1992, Journal of leukocyte biology.

[6]  C. Dinarello.  Role of Interleukin‐l in Infectious Diseases , 1992 .

[7]  K. Matsushima,et al.  Interleukin-1 beta stimulates human mesangial cells to synthesize and release interleukins-6 and -8. , 1991, Kidney international.

[8]  J. Halgunset,et al.  Cytokine-associated tissue injury and lethality in mice: a comparative study. , 1991, Clinical immunology and immunopathology.

[9]  W. Baricos,et al.  Proteolytic enzymes as mediators of glomerular injury. , 1991, Kidney international.

[10]  Z. Hruby,et al.  Antiserum against tumor necrosis factor-alpha and a protease inhibitor reduce immune glomerular injury. , 1991, Kidney international.

[11]  D. Remick,et al.  Endotoxin-induced cytokine gene expression in vivo. III. IL-6 mRNA and serum protein expression and the in vivo hematologic effects of IL-6. , 1991, Journal of immunology.

[12]  D. Remick,et al.  In vivo biologic and immunohistochemical analysis of interleukin-1 alpha, beta and tumor necrosis factor during experimental endotoxemia. Kinetics, Kupffer cell expression, and glucocorticoid effects. , 1991, The American journal of pathology.

[13]  U. Ikeda,et al.  Recombinant interleukin‐1α inhibits the growth of rat mesangial cells in culture , 1991, The American journal of pathology.

[14]  J. Abrams,et al.  Anti-IL-6 monoclonal antibodies protect against lethal Escherichia coli infection and lethal tumor necrosis factor-alpha challenge in mice. , 1990, Journal of immunology.

[15]  L. Aarden,et al.  The relation among stress, adrenalin, interleukin 6 and acute phase proteins in the rat. , 1990, Clinical immunology and immunopathology.

[16]  P. Braquet,et al.  Interleukin-6 production by tumor necrosis factor and lipopolysaccharide-stimulated rat renal cells. , 1990, Clinical immunology and immunopathology.

[17]  J. Lacy,et al.  Interleukin 6 is an autocrine growth factor for mesangial cells. , 1990, Kidney international.

[18]  W. Fiers,et al.  Tumor necrosis factor induces the production of urokinase-type plasminogen activator by human endothelial cells. , 1990, Blood.

[19]  R. Mertelsmann,et al.  Inducible production of interleukin-6 by human polymorphonuclear neutrophils: role of granulocyte-macrophage colony-stimulating factor and tumor necrosis factor-alpha. , 1990, Blood.

[20]  A. Vander,et al.  Role of interleukin 6 in fever in rats. , 1990, The American journal of physiology.

[21]  A. Muraguchi,et al.  Involvement of IL-6 in mesangial proliferative glomerulonephritis. , 1989, Journal of immunology.

[22]  A. Waage,et al.  Endotoxin, tumor necrosis factor-α and interleukin 1 induce interleukin 6 production in vivo , 1989 .

[23]  L. G. Thijs,et al.  Increased plasma levels of interleukin-6 in sepsis [see comments] , 1989 .

[24]  H. Nakagawa,et al.  Effect of acute-phase proteinase inhibitors on chemotaxis of rat polymorphonuclear leukocytes in vitro. , 1989, Journal of pharmacobio-dynamics.

[25]  A. Rees,et al.  Modulation of antibody-mediated glomerular injury in vivo by bacterial lipopolysaccharide, tumor necrosis factor, and IL-1. , 1989, Journal of immunology.

[26]  J. Oudinet,et al.  Production of tumor necrosis factor by rat mesangial cells in response to bacterial lipopolysaccharide. , 1989, Kidney international.

[27]  L. Aarden,et al.  Comparison of the effects of recombinant interleukin 6 and recombinant interleukin 1 on nonspecific resistance to infection , 1989, European journal of immunology.

[28]  A. Meager,et al.  Assays for tumour necrosis factor and related cytokines. , 1989, Journal of immunological methods.

[29]  H. Imura,et al.  Interleukin-6 stimulates the secretion of adrenocorticotropic hormone in conscious, freely-moving rats. , 1988, Biochemical and biophysical research communications.

[30]  T. Hirano,et al.  Induction of rat acute‐phase proteins by interleukin 6 in vivo , 1988, European journal of immunology.

[31]  M. Tykocinski,et al.  The interleukin 1 gene is expressed by rat glomerular mesangial cells and is augmented in immune complex glomerulonephritis. , 1987, Journal of immunology.

[32]  R. Simpson,et al.  Identification of the human 26-kD protein, interferon beta 2 (IFN-beta 2), as a B cell hybridoma/plasmacytoma growth factor induced by interleukin 1 and tumor necrosis factor , 1987, The Journal of experimental medicine.

[33]  P. King,et al.  Severe deficiency of alpha 1-antitrypsin associated with cutaneous vasculitis, rapidly progressive glomerulonephritis, and colitis. , 1985, The American journal of medicine.

[34]  Kazuyoshi Watanabe,et al.  Changes in serum and exudate levels of functional macroglobulins and anti-inflammatory effect of α2-acute-phase macroglobulin on carrageenin-induced inflammation in rats , 1984 .

[35]  E. Fuchs,et al.  Expression of human alpha-tubulin genes: interspecies conservation of 3' untranslated regions , 1983, Molecular and cellular biology.

[36]  P. Lansdorp,et al.  Human endothelial culture supernatant (HECS): a growth factor for hybridomas. , 1980, Journal of immunology.

[37]  T. Miller,et al.  The rapid isolation of ribonuclease-free immunoglobulin G by protein A-sepharose affinity chromatography. , 1978, Journal of immunological methods.

[38]  E. Unanue,et al.  A ROLE OF POLYMORPHONUCLEAR LEUKOCYTES AND COMPLEMENT IN NEPHROTOXIC NEPHRITIS , 1965, The Journal of experimental medicine.

[39]  P. Tipping,et al.  Glomerular interleukin 1 production is dependent on macrophage infiltration in anti-GBM glomerulonephritis. , 1991, Kidney international.

[40]  D. Remick,et al.  Intratracheal injection of endotoxin and cytokines. II. Interleukin-6 and transforming growth factor beta inhibit acute inflammation. , 1991, The American journal of pathology.

[41]  J. Vincent,et al.  Interleukin-6 administration has no acute hemodynamic or hematologic effect in the dog. , 1991, Cytokine.

[42]  C. Dinarello,et al.  Correlations and interactions in the production of interleukin-6 (IL-6), IL-1, and tumor necrosis factor (TNF) in human blood mononuclear cells: IL-6 suppresses IL-1 and TNF. , 1990, Blood.

[43]  K. Matsumoto,et al.  Production of interleukin 1 in glomerular cell cultures from rats with nephrotoxic serum nephritis. , 1989, Clinical and experimental immunology.

[44]  T. Ulich,et al.  In vivo hematologic effects of recombinant interleukin-6 on hematopoiesis and circulating numbers of RBCs and WBCs. , 1989, Blood.

[45]  T. Hirano,et al.  Molecular regulation of B lymphocyte response. , 1988, Annual review of immunology.

[46]  K. Matsumoto,et al.  Production of interleukin 1 in glomerular cell cultures from patients with rapidly progressive crescentic glomerulonephritis. , 1988, American journal of nephrology.

[47]  R. Nordan,et al.  Comparison of in vivo effects of human recombinant IL 1 and human recombinant IL 6 in mice. , 1988, Lymphokine research.

[48]  J. Chirgwin,et al.  Isolation of RNA using guanidinium salts. , 1987, Methods in enzymology.

[49]  P. Lansdorp,et al.  Production of hybridoma growth factor by human monocytes , 1987, European journal of immunology.